Min Xue

909 total citations
28 papers, 700 citations indexed

About

Min Xue is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Min Xue has authored 28 papers receiving a total of 700 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 13 papers in Cancer Research and 4 papers in Oncology. Recurrent topics in Min Xue's work include MicroRNA in disease regulation (9 papers), Cancer-related molecular mechanisms research (8 papers) and Circular RNAs in diseases (7 papers). Min Xue is often cited by papers focused on MicroRNA in disease regulation (9 papers), Cancer-related molecular mechanisms research (8 papers) and Circular RNAs in diseases (7 papers). Min Xue collaborates with scholars based in China, United States and Australia. Min Xue's co-authors include Bin Shan, Ying Zhuo, Yueran Li, Sili He, Zhongqiu Lin, Bin Jiang, Lan Zhang, Qiong Pan, Yajun Wan and Lijie Li and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Journal of Cellular Biochemistry.

In The Last Decade

Min Xue

26 papers receiving 690 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Min Xue China 14 481 396 93 65 64 28 700
Yonggang Wang China 14 389 0.8× 288 0.7× 122 1.3× 60 0.9× 53 0.8× 30 660
Huiying Chi China 11 446 0.9× 298 0.8× 52 0.6× 87 1.3× 24 0.4× 15 696
Jun Zheng China 15 310 0.6× 174 0.4× 109 1.2× 56 0.9× 43 0.7× 45 593
Rangasudhagar Radhakrishnan United States 13 424 0.9× 158 0.4× 123 1.3× 75 1.2× 48 0.8× 28 599
Mingning Qiu China 16 380 0.8× 177 0.4× 62 0.7× 34 0.5× 44 0.7× 27 603
Chang Xu China 14 372 0.8× 215 0.5× 171 1.8× 68 1.0× 50 0.8× 32 607
Dan Fan China 10 525 1.1× 346 0.9× 116 1.2× 38 0.6× 67 1.0× 19 793
Shaobing Cheng China 17 512 1.1× 383 1.0× 106 1.1× 39 0.6× 68 1.1× 29 751
Jiagui Song China 14 415 0.9× 205 0.5× 99 1.1× 44 0.7× 53 0.8× 24 581

Countries citing papers authored by Min Xue

Since Specialization
Citations

This map shows the geographic impact of Min Xue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Min Xue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Min Xue more than expected).

Fields of papers citing papers by Min Xue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Min Xue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Min Xue. The network helps show where Min Xue may publish in the future.

Co-authorship network of co-authors of Min Xue

This figure shows the co-authorship network connecting the top 25 collaborators of Min Xue. A scholar is included among the top collaborators of Min Xue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Min Xue. Min Xue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lu, Yao, et al.. (2025). Case Report: A family of congenital cataract caused by a novel mutation in the CRYGC gene c.52G>A. Frontiers in Medicine. 12. 1624834–1624834.
2.
Wang, Chen, Jie Zeng, Lijie Li, Min Xue, & Sili He. (2021). Cdc25A inhibits autophagy-mediated ferroptosis by upregulating ErbB2 through PKM2 dephosphorylation in cervical cancer cells. Cell Death and Disease. 12(11). 1055–1055. 66 indexed citations
3.
Zhu, Xiaogang, et al.. (2020). Knockdown of ALPK2 inhibits the development and progression of Ovarian Cancer. Cancer Cell International. 20(1). 267–267. 6 indexed citations
4.
Pan, Qiong, Ke Guo, Min Xue, & Qiuyun Tu. (2020). Estrogen protects neuroblastoma cell from amyloid-β 42 (Aβ42)-induced apoptosis via TXNIP/TRX axis and AMPK signaling. Neurochemistry International. 135. 104685–104685. 23 indexed citations
5.
Jiang, Bin, et al.. (2019). MiR-217 Inhibits M2-Like Macrophage Polarization by Suppressing Secretion of Interleukin-6 in Ovarian Cancer. Inflammation. 42(5). 1517–1529. 43 indexed citations
6.
Xue, Min, et al.. (2019). <p>miR-139 Controls Viability Of Ovarian Cancer Cells Through Apoptosis Induction And Exosome Shedding Inhibition By Targeting ATP7A</p>. OncoTargets and Therapy. Volume 12. 10727–10737. 10 indexed citations
7.
Li, Yueran, et al.. (2018). MircroRNA-139 sensitizes ovarian cancer cell to cisplatin-based chemotherapy through regulation of ATP7A/B. Cancer Chemotherapy and Pharmacology. 81(5). 935–947. 36 indexed citations
8.
Xue, Min, Ying Zhuo, & Bin Shan. (2017). MicroRNAs, Long Noncoding RNAs, and Their Functions in Human Disease. Methods in molecular biology. 1617. 1–25. 121 indexed citations
9.
Zeng, Fei, Min Xue, Ting Xiao, et al.. (2016). MiR-200b promotes the cell proliferation and metastasis of cervical cancer by inhibiting FOXG1. Biomedicine & Pharmacotherapy. 79. 294–301. 34 indexed citations
10.
Xue, Min, et al.. (2016). Long noncoding RNA MALAT1-regulated microRNA 506 modulates ovarian cancer growth by targeting iASPP. OncoTargets and Therapy. Volume 10. 35–46. 62 indexed citations
11.
12.
Hu, Yuan, et al.. (2016). [A case report for primary yolk sac tumor of endometrium].. PubMed. 41(12). 1362–1365. 3 indexed citations
13.
Xue, Min, et al.. (2015). Analysis and study of intraocular pressure, visual field and P-ERG on patients with big cup/disk. SHILAP Revista de lepidopterología. 1 indexed citations
14.
15.
Xiao, Songshu, Yanhong Zhou, Yi Wei, et al.. (2015). Fra-1 is downregulated in cervical cancer tissues and promotes cervical cancer cell apoptosis by p53 signaling pathway in vitro. International Journal of Oncology. 46(4). 1677–1684. 37 indexed citations
16.
Li, Lijie, et al.. (2015). [Effect of nano-realgar on proliferation and apoptosis of human cervical carcinoma cells].. PubMed. 40(10). 1068–75. 4 indexed citations
17.
Li, Yueran, et al.. (2014). P16INK4A is required for cisplatin resistance in cervical carcinoma SiHa cells. Oncology Letters. 9(3). 1104–1108. 12 indexed citations
18.
Xiao, Songshu, Yanhong Zhou, Jianfa Jiang, Le Yuan, & Min Xue. (2014). CD44 affects the expression level of FOS-like antigen 1 in cervical cancer tissues. Molecular Medicine Reports. 9(5). 1667–1674. 10 indexed citations
19.
Liao, Shan, et al.. (2014). High expression of octamer transcription factor 1 in cervical cancer. Oncology Letters. 7(6). 1889–1894. 26 indexed citations
20.
Zemtsov, Alexander, Thian C. Ng, & Min Xue. (1989). Human In Vivo 31P Spectroscopy of Skin: Potentially a Powerful Tool for Noninvasive Study of Metabolism in a Cutaneous Tissue. The Journal of Dermatologic Surgery and Oncology. 15(11). 1207–1211. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026